FDCDDQ
MNTA

Federation des caisses Desjardins du Quebec’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,011
Closed -$118K – 2195
2017
Q2 		$118K Sell
7,011
-19,953
-74% -$304K ﹤0.01% 1156
2017
Q1 		$360K Buy
+26,964
New +$422K 0.01% 784

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's MNTA Position: Q3 2017 in Review

Federation des caisses Desjardins du Quebec sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2017, closing a stake of 7,011 shares — an estimated $118K sold.

Federation des caisses Desjardins du Quebec first reported a position in MNTA in Q1 2017 and held it in 2 quarters. The position peaked at $360K in Q1 2017. 158 funds tracked by Wall St. Rank hold MNTA as of Q3 2017.

  • Federation des caisses Desjardins du Quebec reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 7,011 Momenta Pharmaceuticals, Inc. shares in Q3 2017, an estimated $118K.
  • Federation des caisses Desjardins du Quebec first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2017 and held it in 2 quarters.
  • Federation des caisses Desjardins du Quebec's Momenta Pharmaceuticals, Inc. position peaked at $360K in Q1 2017.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2017.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2017, filed 30 Aug 2024.